BOLT: boltbio.com Kompaniya qiymatining sof foydaga nisbati
Bolt Biotherapeutics (BOLT) kompaniyasining -0.40 koeffitsiyentiga ega bo'lgan ushbu kunlik narxlar grafigi immun dorilar ishlab chiquvchi kompaniyadan bozorning kutganlarini aks ettiradi. Biznes muvaffaqiyati o'simliklar terapiyasida antitanachlarning tasdiqlangan samaradorligiga, usullarning xavfsizligiga va sanoat gigantlari bilan hamkorlikka bog'liq. O'sish ISAC-konjugatlarini ishlab chiqishdagi yutuqlar va xarajatlarning kamayishi bilan ta'minlanmoqda, eski dasturlarning yopilishidan so'ng esa R&D markazi platformalarni yangilamoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_BOLT_-_Bolt-Biotherapeutics_-_PE-Multiple "BOLT: Bolt Bio Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Bolt Biotherapeutics Inc. (BOLT) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Bolt Biotherapeutics|BOLT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Bolt Bio|BOLT - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Bolt Biotherapeutics, Inc.|BOLT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Bolt Biotherapeutics|Tezkor likvidlik boltbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
BOLT - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Bolt Biotherapeutics|BOLT - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Bolt Bio|BOLT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Bolt Biotherapeutics, Inc.|BOLT - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Bolt Biotherapeutics|BOLT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi boltbio.com|BOLT - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Bolt Biotherapeutics
Kompaniyaning har tomonlama tahlili:boltbio.com BOLT
P/E koeffitsiyenti aksiyaning bozor qiymatini kompaniyaning sof foydasi bilan solishtirgan holda qoplash muddatini baholaydi va investitsiyaning ishonchliligini belgilaydi. Bolt Biotherapeutics (BOLT) kompaniyasining P/E trayektoriyasini tahlil qilish orqali investor haddan tashqari ko'p to'lov qilish risklarini aniqlashi mumkin, bu esa asosiy onkologik dori vositasining muvaffaqiyatsizligi va ishchi kuchining keng ko'lamli qisqartirilishidan keyingi restrukturizatsiya hamda tadqiqot yo'nalishining o'zgarishi davridagi Bolt Biotherapeutics (BOLT) uchun juda muhimdir.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML: Narxning foydaga nisbati|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narxning foydaga nisbati UPB|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|Bozor narxining sof foydaga nisbati IMNM|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati KALV|Septerna - P/E multiplikatori|PVLA: Narxning foydaga nisbati|SVRA: P/E multiplikatori|RIGL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati AnaptysBio, Inc.|Kapitalizatsiyaning foydaga nisbati astriatx.com ATXS|Narx-foyda koeffitsiyenti ENGN (enGene)|Bozor narxining sof foydaga nisbati RAPT|P/E multiplikatori JBIO (Aerovate Therapeutics)|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati tizianalifesciences.com|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Ventyx Biosciences Inc. - Kompaniya qiymatining sof foydaga nisbati|THTX (Theratechnologies Inc) - P/E multiplikatori|P/E multiplikatori Avalo Therapeutics Inc|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|AGEN: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori CLYM (Climb Bio)|Zura Bio Ltd (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|ADAG - P/E multiplikatori|IMA (ikenaoncology.com) - Narx-foyda koeffitsiyenti|STTK: Bozor narxining sof foydaga nisbati|EQ (Equillium Inc) - P/E multiplikatori|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori IMUX|Narx-foyda koeffitsiyenti atarabio.com ATRA|Narxning foydaga nisbati InflaRx IFRX|Biznesning o‘zini qoplash muddati x4pharma.com (XFOR)|Adicet - P/E multiplikatori|CELU: Narxning foydaga nisbati|INmune Bio Corp (INMB) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Barinthus Biotherapeutics Corp (BRNS)|Narxning foydaga nisbati Kezar Life Sciences|Narxning foydaga nisbati SABS|Narx-foyda koeffitsiyenti AKTX (Akari Therapeutics Plc)|Bozor narxining sof foydaga nisbati ENLV|Narxning foydaga nisbati Q32 Bio QTTB|GOVX (GeoVax Corp) - Kapitalizatsiyaning sof foydaga nisbati|Edesa Biotech, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati IBIO (ibioinc.com)|CARM: P/E multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - P/E multiplikatori|Narxning foydaga nisbati HCW Biologics, Inc.|APVO: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|P/E multiplikatori GRI (GRI Bio)|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati REVB (Revelation Biosciences Corp)|INDP: P/E multiplikatori|SCNI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|IGM Biosciences - Narx-foyda koeffitsiyenti|P/E multiplikatori iteostherapeutics.com ITOS|OCEA - Narxning foydaga nisbati|TCBP (TC BioPharm (Holdings) Plc) - Narx-foyda multiplikatori|THRD: P/E multiplikatori
